Myriad Genetics, Inc. (MYGN)
4.28
-0.34
(-7.36%)
USD |
NASDAQ |
Mar 27, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Profit Margin (Quarterly) : -3.77% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.71% |
| Insulet Corp. | 12.96% |
| Pacific Biosciences of California, Inc. | -90.43% |
| Tandem Diabetes Care, Inc. | -0.20% |
| iRhythm Holdings, Inc. | 2.67% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.17% |
| Return on Assets | -44.13% |
| Return on Invested Capital | -53.66% |
| Gross Profit Margin (Quarterly) | 66.87% |
| Operating Margin (Quarterly) | -1.43% |
| Return on Net Operating Assets | -53.92% |